Monthly Archives: July 2024

A video explaining the recent improvements to the price concessions process is now available for community pharmacy teams to watch. Part of Community Pharmacy England’s ‘Funding & Reimbursement Shorts’ series, the new video guides viewers through recent changes to the price concession process. The regular series of short videos, launched to enhance understanding of common [...]

The post Funding & Reimbursement Shorts: Price concessions appeared first on Community Pharmacy England.

A series of documents have been published by Community Pharmacy England, following discussion of many of the key points and themes at regional meetings with pharmacy owners this summer. The briefings talk pharmacy owners and LPCs through key aspects of our strategy and workplans for the current year, and set out how levy monies have [...]

The post Community Pharmacy England and LPCs complete representation changes appeared first on Community Pharmacy England.

The ability of pharmacy owners to achieve the thresholds for the monthly Pharmacy First payment has been a topic of great concern for pharmacy owners and Community Pharmacy England, particularly as the August increase to 20 clinical pathways got closer. We have been discussing this issue over the last few weeks with the Department of [...]

The post Change to August Pharmacy First monthly threshold appeared first on Community Pharmacy England.

Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) Drug alert number: EL (24)A/33 MDR number: MDR 113-05/24 Date issued: 30 July 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard [...]

The post MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.